Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis

Genes Chromosomes and Cancer

Volumn 53, Issue 8, 2014, Pages 693-702

  Guled, Mohamed ^a   Pazzaglia, Laura ^b   Borze, Ioana ^a   Mosakhani, Neda ^a   Novello, Chiara ^b   Benassi, Maria Serena ^b   Knuutila, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 199A 3P; MICRORNA 199B 5P; MICRORNA 22; MICRORNA 320A; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; CDK4 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMP3 GENE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MDM2 GENE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ROR2 GENE; SOFT TISSUE SARCOMA; UNDIFFERENTIATED PLEOMORPHIC SARCOMA; UPA GENE; AGED; CELL DIFFERENTIATION; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENETICS; LIPOSARCOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902163556     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22179     Document Type: Article

References (37)

1. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
2. Benassi MS, Ponticelli F, Azzoni E, Gamberi G, Pazzaglia L, Chiechi A, Conti A, Spessotto P, Scapolan M, Pignotti E, Bacchini P, Picci P. 2007. Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas. Histol Histopathol 22:1017-1024.
3. Borze I, Guled M, Musse S, Raunio A, Elonen E, Saarinen-Pihkala U, Karjalainen-Lindsberg ML, Lahti L, Knuutila S. 2011. MicroRNA microarrays on archive bone marrow core biopsies of leukemias-Method validation. Leuk Res 35:188-195.
4. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
5. Chen JJ, Zhou SH. 2011. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18:675-681.
6. Cornejo K, Shi M, Jiang Z. 2012. Oncofetal protein IMP3: A useful diagnostic biomarker for leiomyosarcoma. Hum Pathol 43:1567-1572.
7. Dalmay T. 2008. MicroRNAs and cancer. J Intern Med 263:366-375.
8. Danielson LS, Menendez S, Attolini CS, Guijarro MV, Bisogna M, Wei J, Socci ND, Levine DA, Michor F, Hernando E. 2010. A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol 177:908-917.
9. Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret A, Louis-Brennetot C, Aurias A, Coindre JM, Guillou L, Pedeutour F, Duval H, Collin C, de Pinieux G. 2011. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24:624-637.
10. Edris B, Espinosa I, Muhlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, Fletcher JA, Beck AH, West RB, Nusse R, van de Rijn M. 2012. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol 227:223-233.
11. Fabbri M, Croce CM, Calin GA. 2008. MicroRNAs. Cancer J 14:1-6.
12. Favreau AJ, Cross EL, Sathyanarayana P. 2012. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 87:442-446.
13. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. 2013. World Health Organization Classifcation of Tumours of Soft Tissue and Bone, 4th ed. Lyon: IARC Press.
14. Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M. 2009. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 4:e4998.
15. Gibault L, Perot G, Chibon F, Bonnin S, Lagarde P, Terrier P, Coindre JM, Aurias A. 2011. New insights in sarcoma oncogenesis: A comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics. J Pathol 223:64-71.
16. Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O. 2010. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 220:71-86.
17. Hasegawa T, Hasegawa F, Hirose T, Sano T, Matsuno Y. 2003. Expression of smooth muscle markers in so called malignant fibrous histiocytomas. J Clin Pathol 56:666-671.
18. Helman LJ, Meltzer P. 2003. Mechanisms of sarcoma development. Nat Rev Cancer 3:685-694.
19. Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q, Zhao RC. 2012. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 21:2531-2540.
20. Ito M, Barys L, O'Reilly T, Young S, Gorbatcheva B, Monahan J, Zumstein-Mecker S, Choong PF, Dickinson I, Crowe P, Hemmings C, Desai J, Thomas DM, Lisztwan J. 2011. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis. Clin Cancer Res 17:416-426.
21. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. 1993. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541.
22. Kresse SH, Ohnstad HO, Bjerkehagen B, Myklebost O, Meza-Zepeda LA. 2010. DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation. PLoS One 5:e15378.
23. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH. 1995. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J Pathol 175:211-217.
24. Laine SK, Alm JJ, Virtanen SP, Aro HT, Laitala-Leinonen TK. 2012. MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem 113:2687-2695.
25. Lopes MA, Nikitakis NG, Ord RA, Sauk J, Jr. 2001. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol 37:566-571.
26. Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA. 2011. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet 204:138-146.
27. Mosakhani N, Guled M, Leen G, Calabuig-Farinas S, Niini T, Machado I, Savola S, Scotlandi K, Lopez-Guerrero JA, Llombart-Bosch A, Knuutila S. 2012. An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma. J Exp Clin Cancer Res 31:24.
28. Niini T, Lahti L, Michelacci F, Ninomiya S, Hattinger CM, Guled M, Bohling T, Picci P, Serra M, Knuutila S. 2011. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone. Genes Chromosomes Cancer 50:291-306.
29. Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F, Picci P, Benassi MS. 2004. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 19:401-411.
30. Raish M, Khurshid M, Ansari MA, Chaturvedi PK, Bae SM, Kim JH, Park EK, Park DC, Ahn WS. 2012. Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. J Cancer Res Clin Oncol 138:1173-1186.
31. Saito Y, Jones PA. 2006. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 5:2220-2222.
32. Sioletic S, dal Cin P, Fletcher CD, Hornick JL. 2013. Well-differentiated and dedifferentiated liposarcoma with prominent myxoid stroma: Analysis of 56 cases. Histopathology 62:287-293.
33. Subramanian S, Lui WO, Lee CH, Espinosa I, Nielsen TO, Heinrich MC, Corless CL, Fire AZ, van de Rijn M. 2008. MicroRNA expression signature of human sarcomas. Oncogene 27:2015-2026.
34. Thayanithy V, Sarver AL, Kartha RV, Li L, Angstadt AY, Breen M, Steer CJ, Modiano JF, Subramanian S. 2012. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 50:171-181.
35. Thway K, Flora R, Shah C, Olmos D, Fisher C. 2012. Diagnostic utility of p16, CDK4 and MDM2 as an immunoistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 36:462-469.
36. Yang J, Du X, Chen K, Ylipaa A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. 2009. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 275:1-8.
37. Yu F, Cui Y, Zhou X, Zhang X, Han J. 2011. Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells. Biosci Trends 5:46-51.